Luther King Capital Management (LKCM)’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$349M Buy
709,494
+21,112
+3% +$11.5M 1.51% 13
2025
Q4
$399M Buy
688,382
+8,263
+1% +$4.67M 1.62% 14
2025
Q3
$330M Sell
680,119
-53,844
-7% -$25.1M 1.36% 16
2025
Q2
$298M Sell
733,963
-34,470
-4% -$14.4M 1.29% 18
2025
Q1
$382M Sell
768,433
-11,373
-1% -$6.16M 1.77% 11
2024
Q4
$406M Sell
779,806
-9,387
-1% -$5.16M 1.76% 11
2024
Q3
$488M Sell
789,193
-2,635
-0.3% -$1.56M 2.1% 7
2024
Q2
$438M Sell
791,828
-10,166
-1% -$5.82M 1.97% 8
2024
Q1
$466M Sell
801,994
-12,353
-2% -$6.93M 2.1% 7
2023
Q4
$432M Sell
814,347
-60,274
-7% -$29.2M 2.08% 7
2023
Q3
$443M Sell
874,621
-7,624
-0.9% -$4.06M 2.3% 5
2023
Q2
$460M Sell
882,245
-23,529
-3% -$12.7M 2.29% 4
2023
Q1
$522M Sell
905,774
-5,667
-0.6% -$3.19M 2.76% 4
2022
Q4
$502M Sell
911,441
-11,881
-1% -$6.3M 2.75% 4
2022
Q3
$468M Sell
923,322
-3,921
-0.4% -$2.19M 2.8% 4
2022
Q2
$504M Sell
927,243
-18,267
-2% -$10.1M 2.82% 4
2022
Q1
$558M Sell
945,510
-59,618
-6% -$34.2M 2.72% 5
2021
Q4
$671M Sell
1,005,128
-17,152
-2% -$10.7M 3.03% 4
2021
Q3
$584M Sell
1,022,280
-10,636
-1% -$5.84M 2.87% 5
2021
Q2
$521M Sell
1,032,916
-11,640
-1% -$5.49M 2.55% 6
2021
Q1
$477M Sell
1,044,556
-88,465
-8% -$42.2M 2.56% 4
2020
Q4
$528M Sell
1,133,021
-48,321
-4% -$22.7M 2.97% 4
2020
Q3
$522M Sell
1,181,342
-22,318
-2% -$9.22M 3.29% 4
2020
Q2
$436M Sell
1,203,660
-6,229
-0.5% -$2.09M 3.02% 5
2020
Q1
$343M Sell
1,209,889
-81,579
-6% -$25.7M 2.97% 4
2019
Q4
$420M Sell
1,291,468
-2,515
-0.2% -$763K 2.8% 3
2019
Q3
$377M Sell
1,293,983
-2,853
-0.2% -$817K 2.74% 3
2019
Q2
$381M Sell
1,296,836
-3,138
-0.2% -$864K 2.78% 4
2019
Q1
$356M Sell
1,299,974
-25,712
-2% -$6.4M 2.72% 4
2018
Q4
$297M Sell
1,325,686
-8,478
-0.6% -$1.99M 2.64% 4
2018
Q3
$326M Sell
1,334,164
-22,334
-2% -$5.14M 2.46% 4
2018
Q2
$281M Sell
1,356,498
-56,083
-4% -$11.9M 2.3% 5
2018
Q1
$292M Sell
1,412,581
-29,172
-2% -$6.12M 2.44% 3
2017
Q4
$274M Sell
1,441,753
-24,018
-2% -$4.6M 2.24% 3
2017
Q3
$277M Sell
1,465,771
-6,839
-0.5% -$1.24M 2.43% 3
2017
Q2
$257M Sell
1,472,610
-15,353
-1% -$2.58M 2.32% 3
2017
Q1
$229M Sell
1,487,963
-24,204
-2% -$3.7M 2.1% 3
2016
Q4
$213M Sell
1,512,167
-58,099
-4% -$8.57M 2.03% 3
2016
Q3
$250M Sell
1,570,266
-6,417
-0.4% -$989K 2.44% 2
2016
Q2
$233M Sell
1,576,683
-56,682
-3% -$8.37M 2.28% 1
2016
Q1
$231M Sell
1,633,365
-35,990
-2% -$4.82M 2.3% 2
2015
Q4
$237M Sell
1,669,355
-23,565
-1% -$3.14M 2.22% 2
2015
Q3
$207M Sell
1,692,920
-18,013
-1% -$2.35M 2.01% 2
2015
Q2
$222M Sell
1,710,933
-84,860
-5% -$11.1M 1.92% 2
2015
Q1
$241M Sell
1,795,793
-19,453
-1% -$2.51M 2.02% 2
2014
Q4
$227M Sell
1,815,246
-13,601
-0.7% -$1.65M 1.83% 2
2014
Q3
$223M Buy
1,828,847
+2,009
+0.1% +$244K 1.83% 2
2014
Q2
$216M Sell
1,826,838
-11,198
-0.6% -$1.32M 1.7% 2
2014
Q1
$221M Sell
1,838,036
-28,879
-2% -$3.43M 1.8% 1
2013
Q4
$208M Buy
1,866,915
+12,619
+0.7% +$1.25M 1.68% 3
2013
Q3
$171M Buy
1,854,296
+111,017
+6% +$10M 1.47% 3
2013
Q2
$148M Buy
+1,743,279
New +$145M 1.37% 4

Other funds holding TMO

Luther King Capital Management (LKCM)'s TMO Position: Q1 2026 in Review

Luther King Capital Management (LKCM) increased its Thermo Fisher Scientific (TMO) stake by 3.1% in Q1 2026, buying an estimated $11.5M and bringing the position to 709,494 shares worth $349M. The position accounts for 1.51% of the portfolio, ranked #13.

Luther King Capital Management (LKCM) first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $671M in Q4 2021. 2,589 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Luther King Capital Management (LKCM) held 709,494 shares of Thermo Fisher Scientific worth $349M as of Q1 2026.
  • Luther King Capital Management (LKCM) bought 21,112 Thermo Fisher Scientific shares in Q1 2026, an estimated $11.5M.
  • Thermo Fisher Scientific made up 1.51% of Luther King Capital Management (LKCM)'s portfolio in Q1 2026, its #13 holding.
  • Luther King Capital Management (LKCM) first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
  • Luther King Capital Management (LKCM)'s Thermo Fisher Scientific position peaked at $671M in Q4 2021.
  • 2,589 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Luther King Capital Management (LKCM)'s 13F filing for Q1 2026, filed 11 May 2026.